Quick Answer
INTENSITY THERAPEUTICS, INC. reported Cash and Equivalents of $11.92 million for fiscal year 2025.
INTENSITY THERAPEUTICS, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $11.92M | +360.3% |
| 2024 | $2.59M | -69.7% |
| 2023 | $8.56M | +552.1% |
| 2022 | $1.31M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.07M | +154.0% | +218.9% |
| June 30, 2025 | $2.22M | -31.6% | +138.5% |
| March 31, 2025 | $929.0K | -87.5% | -64.1% |
| December 31, 2024 | $2.59M | -69.7% | -6.9% |
| September 30, 2024 | $2.78M | -58.4% | -14.2% |
| June 30, 2024 | $3.24M | +2287.2% | -56.5% |
| March 31, 2024 | $7.46M | -12.8% | -12.8% |
| December 31, 2023 | $8.56M | +552.2% | +27.8% |
- INTENSITY THERAPEUTICS, INC. showed an increase of +360.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2022–2025 period, INTENSITY THERAPEUTICS, INC.’s cash and equivalents has grown by 808.6% (from $1.31 million to $11.92 million).
- The most recent figure is from INTENSITY THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: